Trial Details
COMPLETEDBasic Information
| Clinical ID | c1685 |
|---|---|
| Identifier | NCT04673357 |
| Trial Title | A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ustekinumab|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Wilmington |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-04-06 |
|---|---|
| Primary Completion Date | 2024-11-28 |
| Completion Date | 2025-03-03 |